Emc Capital Management Emergent Bio Solutions Inc. Transaction History

Emc Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$3.17 - $7.91 $5,763 - $14,380	1,818 Added 84.68%	3,965 $13,000
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $13,362 - $24,015	-1,818 Reduced 45.85%	2,147 $397,000
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $1,188 - $2,316	108 Added 2.8%	3,965 $47,000
Q2 2022 Aug 12, 2022	BUY	$27.42 - $43.63 $35,289 - $56,151	1,287 Added 50.08%	3,857 $120,000
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $93,753 - $134,205	2,570 New	2,570 $83,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.